Who's buying Hepion Pharmaceuticals, Inc.?

HEPA insider buying, 13F and 13D filings

• Oct 26, 202613D stake (no activist plan)
  Gravitas Collective Corp.: New Schedule 13D: 19.9% stake
  The Common Stock owned by the Reporting Person was acquired for investment purposes. The Reporting Person may make further acquisitions of the Common Stock from time to time. Except for the foregoing, the Reporting Person has no plans or proposals which relate to, or could result…
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.